ASX - By Stock
|
ACW |
Re:
Ann: Review of 2020 and outlook
|
|
Stungun
|
59 |
21K |
1 |
21/01/21 |
21/01/21 |
ASX - By Stock
|
59
|
21K
|
1
|
|
ASX - By Stock
|
ACW |
Re:
MEDIA ATTENTION & GENERAL NEWS/AWARENESS THREAD
|
|
Stungun
|
159 |
55K |
1 |
19/01/21 |
19/01/21 |
ASX - By Stock
|
159
|
55K
|
1
|
|
ASX - By Stock
|
ACW |
Re:
MEDIA ATTENTION & GENERAL NEWS/AWARENESS THREAD
|
|
Stungun
|
159 |
55K |
1 |
12/01/21 |
12/01/21 |
ASX - By Stock
|
159
|
55K
|
1
|
|
ASX - By Stock
|
ACW |
Re:
MEDIA ATTENTION & GENERAL NEWS/AWARENESS THREAD
|
|
Stungun
|
159 |
55K |
7 |
23/12/20 |
23/12/20 |
ASX - By Stock
|
159
|
55K
|
7
|
|
ASX - By Stock
|
ACW |
Re:
MEDIA ATTENTION & GENERAL NEWS/AWARENESS THREAD
|
|
Stungun
|
159 |
55K |
11 |
23/12/20 |
23/12/20 |
ASX - By Stock
|
159
|
55K
|
11
|
|
ASX - By Stock
|
ACW |
Re:
CEO Interview
|
|
Stungun
|
14 |
2.2K |
2 |
02/11/20 |
02/11/20 |
ASX - By Stock
|
14
|
2.2K
|
2
|
|
ASX - By Stock
|
ACW |
Re:
MEDIA ATTENTION & GENERAL NEWS/AWARENESS THREAD
|
|
Stungun
|
159 |
55K |
1 |
29/10/20 |
29/10/20 |
ASX - By Stock
|
159
|
55K
|
1
|
|
ASX - By Stock
|
ACW |
Re:
MEDIA ATTENTION & GENERAL NEWS/AWARENESS THREAD
|
|
Stungun
|
159 |
55K |
1 |
22/10/20 |
22/10/20 |
ASX - By Stock
|
159
|
55K
|
1
|
|
ASX - By Stock
|
ACW |
Re:
Ann: Actinogen Presentation & Planned Conference Call
|
|
Stungun
|
31 |
5.6K |
0 |
21/10/20 |
21/10/20 |
ASX - By Stock
|
31
|
5.6K
|
0
|
|
ASX - By Stock
|
ACW |
Re:
Ann: Actinogen Presentation & Planned Conference Call
|
|
Stungun
|
31 |
5.6K |
2 |
21/10/20 |
21/10/20 |
ASX - By Stock
|
31
|
5.6K
|
2
|
|
ASX - By Stock
|
ACW |
Re:
Ann: Actinogen Presentation & Planned Conference Call
|
|
Stungun
|
31 |
5.6K |
0 |
19/10/20 |
19/10/20 |
ASX - By Stock
|
31
|
5.6K
|
0
|
|
ASX - By Stock
|
ACW |
Re:
Ann: Actinogen Presentation & Planned Conference Call
|
|
Stungun
|
31 |
5.6K |
1 |
19/10/20 |
19/10/20 |
ASX - By Stock
|
31
|
5.6K
|
1
|
|
ASX - By Stock
|
ACW |
Re:
Ann: ACW announces two clinical trials & launches capital raising
|
|
Stungun
|
36 |
10K |
0 |
15/10/20 |
15/10/20 |
ASX - By Stock
|
36
|
10K
|
0
|
|
ASX - By Stock
|
ACW |
Re:
Ann: Actinogen Medical Investor Presentation
|
|
Stungun
|
58 |
18K |
1 |
15/09/20 |
15/09/20 |
ASX - By Stock
|
58
|
18K
|
1
|
|
ASX - By Stock
|
ACW |
Re:
ASX Small & Mid Cap Conference [video]
|
|
Stungun
|
3 |
1.0K |
3 |
08/09/20 |
08/09/20 |
ASX - By Stock
|
3
|
1.0K
|
3
|
|
ASX - By Stock
|
ACW |
Re:
could see .04
|
|
Stungun
|
160 |
40K |
1 |
07/09/20 |
07/09/20 |
ASX - By Stock
|
160
|
40K
|
1
|
|
ASX - By Stock
|
ACW |
Re:
MEDIA ATTENTION & GENERAL NEWS/AWARENESS THREAD
|
|
Stungun
|
159 |
55K |
4 |
22/08/20 |
22/08/20 |
ASX - By Stock
|
159
|
55K
|
4
|
|
ASX - By Stock
|
ACW |
Re:
MEDIA ATTENTION & GENERAL NEWS/AWARENESS THREAD
|
|
Stungun
|
159 |
55K |
4 |
13/08/20 |
13/08/20 |
ASX - By Stock
|
159
|
55K
|
4
|
|
ASX - By Stock
|
ACW |
Re:
MEDIA ATTENTION & GENERAL NEWS/AWARENESS THREAD
|
|
Stungun
|
159 |
55K |
1 |
12/08/20 |
12/08/20 |
ASX - By Stock
|
159
|
55K
|
1
|
|
ASX - By Stock
|
ACW |
Re:
MEDIA ATTENTION & GENERAL NEWS/AWARENESS THREAD
|
|
Stungun
|
159 |
55K |
2 |
07/08/20 |
07/08/20 |
ASX - By Stock
|
159
|
55K
|
2
|
|
ASX - By Stock
|
ACW |
Re:
MEDIA ATTENTION & GENERAL NEWS/AWARENESS THREAD
|
|
Stungun
|
159 |
55K |
5 |
05/08/20 |
05/08/20 |
ASX - By Stock
|
159
|
55K
|
5
|
|
ASX - By Stock
|
ACW |
Re:
MEDIA ATTENTION & GENERAL NEWS/AWARENESS THREAD
|
|
Stungun
|
159 |
55K |
7 |
04/08/20 |
04/08/20 |
ASX - By Stock
|
159
|
55K
|
7
|
|
ASX - By Stock
|
ACW |
Re:
could see .04
|
|
Stungun
|
160 |
40K |
6 |
04/08/20 |
04/08/20 |
ASX - By Stock
|
160
|
40K
|
6
|
|
ASX - By Stock
|
ACW |
Re:
Ann: Quarterly Activity Report & Appendix 4C
|
|
Stungun
|
19 |
4.3K |
1 |
01/08/20 |
01/08/20 |
ASX - By Stock
|
19
|
4.3K
|
1
|
|
ASX - By Stock
|
ACW |
Re:
Ann: Quarterly Activity Report & Appendix 4C
|
|
Stungun
|
19 |
4.3K |
2 |
30/07/20 |
30/07/20 |
ASX - By Stock
|
19
|
4.3K
|
2
|
|
ASX - By Stock
|
ACW |
Re:
Ann: Quarterly Activity Report & Appendix 4C
|
|
Stungun
|
19 |
4.3K |
14 |
30/07/20 |
30/07/20 |
ASX - By Stock
|
19
|
4.3K
|
14
|
|
ASX - By Stock
|
ACW |
Re:
could see .04
|
|
Stungun
|
160 |
40K |
2 |
25/07/20 |
25/07/20 |
ASX - By Stock
|
160
|
40K
|
2
|
|
ASX - By Stock
|
ACW |
Re:
could see .04
|
|
Stungun
|
160 |
40K |
1 |
21/07/20 |
21/07/20 |
ASX - By Stock
|
160
|
40K
|
1
|
|
ASX - By Stock
|
ACW |
Re:
could see .04
|
|
Stungun
|
160 |
40K |
2 |
17/07/20 |
17/07/20 |
ASX - By Stock
|
160
|
40K
|
2
|
|
ASX - By Stock
|
ACW |
Re:
could see .04
|
|
Stungun
|
160 |
40K |
1 |
16/07/20 |
16/07/20 |
ASX - By Stock
|
160
|
40K
|
1
|
|
ASX - By Stock
|
ACW |
Re:
Ann: Market Update and ACW to Participate in BIO Digital
|
|
Stungun
|
108 |
31K |
1 |
11/07/20 |
11/07/20 |
ASX - By Stock
|
108
|
31K
|
1
|
|
ASX - By Stock
|
ACW |
Re:
Ann: Response to ASX Price Query
|
|
Stungun
|
23 |
7.3K |
1 |
08/07/20 |
08/07/20 |
ASX - By Stock
|
23
|
7.3K
|
1
|
|
ASX - By Stock
|
ACW |
Re:
Ann: Response to ASX Price Query
|
|
Stungun
|
23 |
7.3K |
0 |
08/07/20 |
08/07/20 |
ASX - By Stock
|
23
|
7.3K
|
0
|
|
ASX - By Stock
|
ACW |
Re:
Ann: Response to ASX Price Query
|
|
Stungun
|
23 |
7.3K |
3 |
03/07/20 |
03/07/20 |
ASX - By Stock
|
23
|
7.3K
|
3
|
|
ASX - By Stock
|
ACW |
Re:
Broken downtrend
|
|
Stungun
|
17 |
4.9K |
2 |
16/06/20 |
16/06/20 |
ASX - By Stock
|
17
|
4.9K
|
2
|
|
ASX - By Stock
|
ACW |
Re:
Ann: Market Update and ACW to Participate in BIO Digital
|
|
Stungun
|
108 |
31K |
3 |
16/06/20 |
16/06/20 |
ASX - By Stock
|
108
|
31K
|
3
|
|
ASX - By Stock
|
ACW |
Re:
Ann: Market Update and ACW to Participate in BIO Digital
|
|
Stungun
|
108 |
31K |
0 |
15/06/20 |
15/06/20 |
ASX - By Stock
|
108
|
31K
|
0
|
|
ASX - By Stock
|
ACW |
Re:
Ann: Market Update and ACW to Participate in BIO Digital
|
|
Stungun
|
108 |
31K |
1 |
12/06/20 |
12/06/20 |
ASX - By Stock
|
108
|
31K
|
1
|
|
ASX - By Stock
|
ACW |
Re:
Ann: Market Update and ACW to Participate in BIO Digital
|
|
Stungun
|
108 |
31K |
1 |
12/06/20 |
12/06/20 |
ASX - By Stock
|
108
|
31K
|
1
|
|
ASX - By Stock
|
ACW |
Re:
11βHSD1 inhibitor use in human disease- a systematic review and narrative synthesis
|
|
Stungun
|
80 |
28K |
2 |
11/05/20 |
11/05/20 |
ASX - By Stock
|
80
|
28K
|
2
|
|
ASX - By Stock
|
ACW |
Re:
Ann: Actinogen presents latest Xanamem data at AD Conference
|
|
Stungun
|
68 |
26K |
2 |
16/04/20 |
16/04/20 |
ASX - By Stock
|
68
|
26K
|
2
|
|
ASX - By Stock
|
ACW |
Re:
Ann: Actinogen presents latest Xanamem data at AD Conference
|
|
Stungun
|
68 |
26K |
2 |
06/04/20 |
06/04/20 |
ASX - By Stock
|
68
|
26K
|
2
|
|
ASX - By Stock
|
ACW |
Re:
Ann: Additional R&D Tax Incentive rebate received
|
|
Stungun
|
52 |
31K |
0 |
09/03/20 |
09/03/20 |
ASX - By Stock
|
52
|
31K
|
0
|
|
ASX - By Stock
|
ACW |
Re:
Ann: Additional R&D Tax Incentive rebate received
|
|
Stungun
|
52 |
31K |
0 |
09/03/20 |
09/03/20 |
ASX - By Stock
|
52
|
31K
|
0
|
|
ASX - By Stock
|
ACW |
Re:
Ann: Additional R&D Tax Incentive rebate received
|
|
Stungun
|
52 |
31K |
0 |
04/03/20 |
04/03/20 |
ASX - By Stock
|
52
|
31K
|
0
|
|
ASX - By Stock
|
ACW |
Re:
Ann: Additional R&D Tax Incentive rebate received
|
|
Stungun
|
52 |
31K |
0 |
04/03/20 |
04/03/20 |
ASX - By Stock
|
52
|
31K
|
0
|
|
ASX - By Stock
|
ACW |
Re:
Ann: Additional R&D Tax Incentive rebate received
|
|
Stungun
|
52 |
31K |
2 |
04/03/20 |
04/03/20 |
ASX - By Stock
|
52
|
31K
|
2
|
|
ASX - By Stock
|
ACW |
Re:
Ann: Additional R&D Tax Incentive rebate received
|
|
Stungun
|
52 |
31K |
4 |
21/02/20 |
21/02/20 |
ASX - By Stock
|
52
|
31K
|
4
|
|
ASX - By Stock
|
ACW |
Re:
Ann: December 2019 Quarterly Update
|
|
Stungun
|
57 |
38K |
6 |
14/02/20 |
14/02/20 |
ASX - By Stock
|
57
|
38K
|
6
|
|
ASX - By Stock
|
ACW |
Re:
Ann: December 2019 Quarterly Update
|
|
Stungun
|
57 |
38K |
5 |
10/02/20 |
10/02/20 |
ASX - By Stock
|
57
|
38K
|
5
|
|